{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:26:08Z","timestamp":1792157168889,"version":"4.4.0"},"reference-count":369,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:00:00Z","timestamp":1620777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["R01ES07331"],"award-info":[{"award-number":["R01ES07331"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["R01ES10563"],"award-info":[{"award-number":["R01ES10563"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_00015\/6"],"award-info":[{"award-number":["MC_UU_00015\/6"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Trace Elements in Medicine and Biology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jtemb.2021.126779","type":"journal-article","created":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T06:55:45Z","timestamp":1621061745000},"page":"126779","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":151,"special_numbering":"C","title":["Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer\u2019s disease: Limitations, and current and future perspectives"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3649-9232","authenticated-orcid":false,"given":"Kehinde D.","family":"Fasae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4203-452X","authenticated-orcid":false,"given":"Amos O.","family":"Abolaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9462-4604","authenticated-orcid":false,"given":"Tolulope R.","family":"Faloye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6512-013X","authenticated-orcid":false,"given":"Atinuke Y.","family":"Odunsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bolaji O.","family":"Oyetayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9368-9016","authenticated-orcid":false,"given":"Joseph I.","family":"Enya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9185-8058","authenticated-orcid":false,"given":"Joshua A.","family":"Rotimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rufus O.","family":"Akinyemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Whitworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Aschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib0005","first-page":"419","article-title":"Alzheimer disease","volume":"22","author":"Apostolova","year":"2016","journal-title":"Lifelong Learning Neurol."},{"issue":"1\u20132","key":"10.1016\/j.jtemb.2021.126779_bib0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000109998","article-title":"Prevalence of dementia in the United States: the aging, demographics, and memory study","volume":"29","author":"Plassman","year":"2007","journal-title":"Neuroepidemiology"},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib0015","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","article-title":"The global prevalence of dementia: a systematic review and metaanalysis","volume":"9","author":"Prince","year":"2013","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"May","key":"10.1016\/j.jtemb.2021.126779_bib0020","article-title":"Exploring the pathogenesis of Alzheimer disease in basal forebrain cholinergic neurons:converging insights from alternative hypotheses","volume":"13","author":"Chen","year":"2019","journal-title":"Front. Neurosci."},{"issue":"10043","key":"10.1016\/j.jtemb.2021.126779_bib0025","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer\u2019s disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib0030","doi-asserted-by":"crossref","DOI":"10.1038\/nrd3842-c2","article-title":"A new roadmap for drug development for Alzheimer\u2019s disease","volume":"13","author":"Becker","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.jtemb.2021.126779_bib0035","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","article-title":"Alzheimer mechanisms and therapeutic strategies","volume":"148","author":"Huang","year":"2012","journal-title":"Cell"},{"issue":"70","key":"10.1016\/j.jtemb.2021.126779_bib0040","doi-asserted-by":"crossref","first-page":"13434","DOI":"10.1039\/C5CC05264E","article-title":"Function and toxicity of amyloid beta and recent therapeutic interventions targeting amyloid beta in Alzheimer\u2019s disease","volume":"51","author":"Rajasekhar","year":"2015","journal-title":"Chem. Commun."},{"issue":"3","key":"10.1016\/j.jtemb.2021.126779_bib0045","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer\u2019s disease wit\u2026 [Neuron. 2003] - PubMed result","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.jtemb.2021.126779_bib0050","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9812178","article-title":"Metals and neuronal metal binding proteins implicated in Alzheimer\u2019s disease","author":"Crist\u00f3v\u00e3o","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"12","key":"10.1016\/j.jtemb.2021.126779_bib0055","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A\u03b2-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jtemb.2021.126779_bib0060","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bcp.2014.01.009","article-title":"The complexities of the pathology-pathogenesis relationship in Alzheimer disease","volume":"88","author":"Castellani","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jtemb.2021.126779_bib0065","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.freeradbiomed.2012.10.558","article-title":"Metallostasis in Alzheimer\u2019s disease","volume":"62","author":"Ayton","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jtemb.2021.126779_bib0070","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ccr.2016.04.013","article-title":"Recent progress in multifunctional metal chelators as potential drugs for Alzheimer\u2019s disease","volume":"327\u2013328","author":"Santos","year":"2016","journal-title":"Coord. Chem. Rev."},{"issue":"10","key":"10.1016\/j.jtemb.2021.126779_bib0075","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1212\/01.wnl.0000271395.29695.9a","article-title":"Relation between smoking and risk of dementia and Alzheimer disease: the Rotterdam Study","volume":"69","author":"Reitz","year":"2007","journal-title":"Neurology"},{"issue":"9303","key":"10.1016\/j.jtemb.2021.126779_bib0080","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0140-6736(02)07493-7","article-title":"Alcohol consumption and risk of dementia: the Rotterdam Study","volume":"359","author":"Ruitenberg","year":"2002","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.jtemb.2021.126779_bib0085","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/j.neurobiolaging.2008.02.010","article-title":"The pathological interaction between diabetes and presymptomatic Alzheimer\u2019s disease","volume":"30","author":"Burdo","year":"2009","journal-title":"Neurobiol. Aging"},{"issue":"SUPPL","key":"10.1016\/j.jtemb.2021.126779_bib0090","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0167-4943(01)00145-5","article-title":"Behavioral disturbances in the Alzheimer\u2019s care units: a six-months observation","volume":"33","author":"Massaia","year":"2001","journal-title":"Arch. Gerontol. Geriatr."},{"issue":"11","key":"10.1016\/j.jtemb.2021.126779_bib0095","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1007\/s001250050588","article-title":"Association of diabetes mellitus and dementia: the Rotterdam Study","volume":"39","author":"Ott","year":"1996","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib0100","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-14-643","article-title":"Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis","volume":"14","author":"Beydoun","year":"2014","journal-title":"BMC Public Health"},{"issue":"4","key":"10.1016\/j.jtemb.2021.126779_bib0105","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jalz.2013.05.1771","article-title":"Plasma nutrient status of patients with Alzheimer\u2019s disease: Systematic review and meta-analysis","volume":"10","author":"Lopes Da Silva","year":"2014","journal-title":"Alzheimer\u2019s. Dementia"},{"key":"10.1016\/j.jtemb.2021.126779_bib0110","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejmech.2014.07.013","article-title":"Flavones: an important scaffold for medicinal chemistry","volume":"84","author":"Singh","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib0115","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jalz.2015.06.1895","article-title":"\u03b2-Amyloid pathogenesis: chemical properties versus cellular levels","volume":"12","author":"Tiwari","year":"2016","journal-title":"Alzheimer\u2019s and Dementia"},{"issue":"4","key":"10.1016\/j.jtemb.2021.126779_bib0120","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/jmv.20133","article-title":"Reactivation of HSV-1 in the brain of patients with familial Alzheimer\u2019s disease","volume":"73","author":"Mori","year":"2004","journal-title":"J. Med. Virol."},{"issue":"6","key":"10.1016\/j.jtemb.2021.126779_bib0125","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.neuropharm.2007.07.013","article-title":"Emantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse","volume":"53","author":"Parsons","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jtemb.2021.126779_bib0130","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.semcdb.2015.03.010","article-title":"Disturbed calcium signaling in spinocerebellar ataxias and Alzheimer\u2019s disease","volume":"40","author":"Egorova","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.jtemb.2021.126779_bib0135","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1590\/S0001-37652009000300011","article-title":"Calcium and cell death signaling in neurodegeneration and aging","volume":"81","author":"Smaili","year":"2009","journal-title":"An. Acad. Bras. Cienc."},{"issue":"March","key":"10.1016\/j.jtemb.2021.126779_bib0140","article-title":"Metal chaperones: a holistic approach to the treatment of alzheimer\u2019s disease","volume":"3","author":"Adlard","year":"2012","journal-title":"Front. Psychiatry"},{"issue":"5","key":"10.1016\/j.jtemb.2021.126779_bib0145","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1039\/C4MT00008K","article-title":"Characterization of biometal profiles in neurological disorders","volume":"6","author":"Pfaender","year":"2014","journal-title":"Metallomics"},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib0150","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s13311-014-0312-z","article-title":"Biometals and their therapeutic implications in alzheimer\u2019s disease","volume":"12","author":"Ayton","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jtemb.2021.126779_bib0155","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.envres.2017.07.048","article-title":"Metals and neurodegenerative diseases. A systematic review","volume":"159","author":"Cicero","year":"2017","journal-title":"Environ. Res."},{"key":"10.1016\/j.jtemb.2021.126779_bib0160","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.arr.2016.10.003","article-title":"Metal ions influx is a double edged sword for the pathogenesis of Alzheimer\u2019s disease","volume":"35","author":"Wang","year":"2017","journal-title":"Ageing Res. Rev."},{"issue":"8","key":"10.1016\/j.jtemb.2021.126779_bib0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20081829","article-title":"Recent developments in metal-based drugs and chelating agents for neurodegenerative diseases treatments","volume":"20","author":"Sales","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.jtemb.2021.126779_bib0170","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.tips.2009.05.002","article-title":"Alzheimer\u2019s disease, metal ions and metal homeostatic therapy","volume":"30","author":"Zatta","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.jtemb.2021.126779_bib0175","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.nurt.2008.05.001","article-title":"Therapeutics for alzheimer\u2019s disease based on the metal hypothesis","volume":"5","author":"Bush","year":"2008","journal-title":"Neurotherapeutics"},{"issue":"19\u201320","key":"10.1016\/j.jtemb.2021.126779_bib0180","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.ccr.2012.03.013","article-title":"Copper, zinc and iron in neurodegenerative diseases (Alzheimer\u2019s, Parkinson\u2019s and prion diseases)","volume":"256","author":"Kozlowski","year":"2012","journal-title":"Coord. Chem. Rev."},{"issue":"9","key":"10.1016\/j.jtemb.2021.126779_bib0185","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1039\/B919237A","article-title":"Minding metals: tailoring multifunctional chelating agents for neurodegenerative disease","volume":"39","author":"Perez","year":"2010","journal-title":"J. Chem. Soc. Dalton Trans."},{"issue":"12","key":"10.1016\/j.jtemb.2021.126779_bib0190","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1517\/13543784.13.12.1585","article-title":"Metal-protein attenuating compounds and Alzheimer\u2019s disease","volume":"13","author":"Ritchie","year":"2004","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"8","key":"10.1016\/j.jtemb.2021.126779_bib0195","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1021\/ar400293h","article-title":"Metal ions and intrinsically disordered proteins and peptides: from Cu\/Zn amyloid-\u03b2 to general principles","volume":"47","author":"Faller","year":"2014","journal-title":"Acc. Chem. Res."},{"issue":"3","key":"10.1016\/j.jtemb.2021.126779_bib0200","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/anie.201508597","article-title":"Free superoxide is an intermediate in the production of H 2 O 2 by copper(I)-A\u03b2 peptide and O 2","volume":"55","author":"Reybier","year":"2016","journal-title":"Angew. Chemie Int. Ed."},{"issue":"4","key":"10.1016\/j.jtemb.2021.126779_bib0205","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.neurobiolaging.2013.10.078","article-title":"Genetic and biochemical markers in patients with Alzheimer\u2019s disease support a concerted systemic iron homeostasis dysregulation","volume":"35","author":"Crespo","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib0210","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1039\/C1CS15112F","article-title":"Misfolded proteins in Alzheimer\u2019s disease and type II diabetes","volume":"41","author":"DeToma","year":"2012","journal-title":"Chem. Soc. Rev."},{"issue":"17","key":"10.1016\/j.jtemb.2021.126779_bib0215","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/anie.200802808","article-title":"Alzheimer\u2019s disease: from pathology to therapeutic approaches","volume":"48","author":"Jakob-Roetne","year":"2009","journal-title":"Angew. Chemie Int. Ed."},{"issue":"42","key":"10.1016\/j.jtemb.2021.126779_bib0220","doi-asserted-by":"crossref","first-page":"23780","DOI":"10.1039\/C8RA03620A","article-title":"Current progress, challenges and future prospects of diagnostic and therapeutic interventions in Alzheimer\u2019s disease","volume":"8","author":"Rajasekhar","year":"2018","journal-title":"RSC Adv."},{"issue":"15","key":"10.1016\/j.jtemb.2021.126779_bib0225","doi-asserted-by":"crossref","first-page":"6865","DOI":"10.1021\/ic201069v","article-title":"Exploring the reactions of \u03b2-Amyloid (A\u03b2) peptide 1-28 with Al III and Fe III ions","volume":"50","author":"Valensin","year":"2011","journal-title":"Inorg. Chem."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2016.07.150","article-title":"The worldwide costs of dementia 2015 and comparisons with 2010","volume":"13","author":"Wimo","year":"2017","journal-title":"Alzheimer\u2019s and Dementia"},{"issue":"4","key":"10.1016\/j.jtemb.2021.126779_bib0235","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/ana.22615","article-title":"Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders","volume":"70","author":"Jucker","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jtemb.2021.126779_bib0240","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.01312","article-title":"New insights into the pathogenesis of alzheimer\u2019s disease","volume":"10","author":"Fan","year":"2020","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib0245","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer\u2019s disease: genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol. Rev."},{"issue":"3","key":"10.1016\/j.jtemb.2021.126779_bib0250","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib0255","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3233\/JAD-2010-1221","article-title":"Alzheimer\u2019s disease and the amyloid-\u03b2 peptide","volume":"19","author":"Murphy","year":"2010","journal-title":"J. Alzheimer Dis."},{"issue":"5580","key":"10.1016\/j.jtemb.2021.126779_bib0260","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000369101","article-title":"Amyloid-beta: a crucial factor in Alzheimer\u2019s disease","volume":"24","author":"Sadigh-Eteghad","year":"2015","journal-title":"Med. Princ. Pract."},{"issue":"C","key":"10.1016\/j.jtemb.2021.126779_bib0270","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","article-title":"Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease","volume":"12","author":"Hardy","year":"1991","journal-title":"Trends Pharmacol. Sci."},{"issue":"6","key":"10.1016\/j.jtemb.2021.126779_bib0275","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nn.4017","article-title":"The case for rejecting the amyloid cascade hypothesis","volume":"18","author":"Herrup","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jtemb.2021.126779_bib0280","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/369808","article-title":"Alzheimer\u2019s disease and the amyloid cascade hypothesis: a critical review","author":"Reitz","year":"2012","journal-title":"Int. J. Alzheimers Dis."},{"issue":"6","key":"10.1016\/j.jtemb.2021.126779_bib0285","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"issue":"20","key":"10.1016\/j.jtemb.2021.126779_bib0290","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1212\/WNL.0b013e3182563bbe","article-title":"Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease","volume":"78","author":"Knopman","year":"2012","journal-title":"Neurology"},{"issue":"40","key":"10.1016\/j.jtemb.2021.126779_bib0295","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1039\/C3CC48473D","article-title":"A small molecule that displays marked reactivity toward copper-versus zinc-amyloid-\u03b2 implicated in Alzheimer\u2019s disease","volume":"50","author":"Savelieff","year":"2014","journal-title":"Chem. Commun."},{"issue":"10","key":"10.1016\/j.jtemb.2021.126779_bib0300","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S1474-4422(13)70194-7","article-title":"Preclinical Alzheimer\u2019s disease and its outcome: a longitudinal cohort study","volume":"12","author":"Vos","year":"2013","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.jtemb.2021.126779_bib0305","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1021\/ml300058m","article-title":"The \u03b2-amyloid hypothesis in Alzheimer\u2019s disease: seeing is believing","volume":"3","author":"Kung","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"issue":"4980","key":"10.1016\/j.jtemb.2021.126779_bib0310","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1126\/science.2218531","article-title":"Neurotrophic and neurotoxic effects of amyloid \u03b2 protein: reversal by tachykinin neuropeptides","volume":"250","author":"Yankner","year":"1990","journal-title":"Science"},{"issue":"January","key":"10.1016\/j.jtemb.2021.126779_bib0315","article-title":"Reconsideration of amyloid hypothesis and tau hypothesis in Alzheimer\u2019s disease","volume":"12","author":"Kametani","year":"2018","journal-title":"Front. Neurosci."},{"issue":"8","key":"10.1016\/j.jtemb.2021.126779_bib0320","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-\u03b2 protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory","volume":"14","author":"Shankar","year":"2008","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.jtemb.2021.126779_bib0325","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nrneurol.2013.223","article-title":"Alzheimer disease therapy\u2014moving from amyloid-\u03b2 to tau","volume":"9","author":"Giacobini","year":"2013","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib0330","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1326-8-15","article-title":"Normal cognition in transgenic BRI2-A\u03b2 mice","volume":"8","author":"Kim","year":"2013","journal-title":"Mol. Neurodegener."},{"issue":"4","key":"10.1016\/j.jtemb.2021.126779_bib0335","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa1304839","article-title":"Two phase 3 trials of Bapineuzumab in mild-to-moderate Alzheimer\u2019s disease","volume":"370","author":"Salloway","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib0340","doi-asserted-by":"crossref","DOI":"10.1186\/alzrt233","article-title":"Open questions for Alzheimer\u2019s disease immunotherapy","volume":"6","author":"Golde","year":"2014","journal-title":"Alzheimers Res. Ther."},{"issue":"11","key":"10.1016\/j.jtemb.2021.126779_bib0345","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1073\/pnas.83.11.4044","article-title":"Microtubule-associated protein tau (\u03c4) is a major antigenic component of paired helical filaments in Alzheimer disease","volume":"83","author":"Kosik","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib0350","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0022-2836(77)90213-3","article-title":"Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin","volume":"116","author":"Cleveland","year":"1977","journal-title":"J. Mol. Biol."},{"issue":"11","key":"10.1016\/j.jtemb.2021.126779_bib0355","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1073\/pnas.73.11.4070","article-title":"Tubulin requires tau for growth into microtubule initiating sites","volume":"73","author":"Witman","year":"1976","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"4","key":"10.1016\/j.jtemb.2021.126779_bib0360","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0896-6273(89)90210-9","article-title":"Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer\u2019s disease","volume":"3","author":"Goedert","year":"1989","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib0365","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4103\/0019-5545.44908","article-title":"Neurobiology of Alzheimer\u2032s disease","volume":"51","author":"Mohandas","year":"2009","journal-title":"Indian J. Psychiatry"},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib0370","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1582-4934.2008.00225.x","article-title":"Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention: alzheimer Review Series","volume":"12","author":"Iqbal","year":"2008","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib0375","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1523\/JNEUROSCI.1550-17.2017","article-title":"A conserved cytoskeletal signaling cascade mediates neurotoxicity of FTDP-17 tau mutations in vivo","volume":"38","author":"Bardai","year":"2018","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.jtemb.2021.126779_bib0380","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.arcmed.2010.03.007","article-title":"The revitalized tau hypothesis on alzheimer\u2019s disease","volume":"41","author":"Maccioni","year":"2010","journal-title":"Arch. Med. Res."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib0385","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF01738910","article-title":"\u00dcber humorale \u00fcbertragbarkeit der herznervenwirkung - I. Mitteilung","volume":"189","author":"Loewi","year":"1921","journal-title":"Pfl\u00fcgers Archiv f\u00fcr die Gesamte Physiologie des Menschen und der Tiere"},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib0390","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/cne.902160106","article-title":"Distribution of cholinergic neurons in rat brain: demonstrated by the immunocytochemical localization of choline acetyltransferase","volume":"216","author":"Armstrong","year":"1983","journal-title":"J. Comp. Neurol."},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib0395","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.bbr.2009.12.046","article-title":"Cholinergic systems mediate action from movement to higher consciousness","volume":"221","author":"Woolf","year":"2011","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib0400","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0306-4522(97)00208-X","article-title":"Learning impairments following injection of a selective cholinergic immunotoxin, ME20.4 IgG-saporin, into the basal nucleus of Meynert in monkeys","volume":"81","author":"Fine","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.jtemb.2021.126779_bib0405","series-title":"Basic Neurochemistry : Molecular, Cellular and Medical Aspects","author":"Taylor","year":"1943"},{"issue":"4","key":"10.1016\/j.jtemb.2021.126779_bib0410","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12272-013-0036-3","article-title":"A review on cholinesterase inhibitors for Alzheimer\u2019s disease","volume":"36","author":"Anand","year":"2013","journal-title":"Arch. Pharm. Res."},{"issue":"4","key":"10.1016\/j.jtemb.2021.126779_bib0415","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0091-3057(96)00431-5","article-title":"Acetylcholine, aging, and Alzheimer\u2019s disease","volume":"56","author":"Muir","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"8000","key":"10.1016\/j.jtemb.2021.126779_bib0420","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(76)91936-X","article-title":"Selective loss of central cholinergic neurons in Alzheimer\u2019S Disease","volume":"308","author":"Davies","year":"1976","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib0425","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0022-510X(81)90106-4","article-title":"Neuropathological and biochemical observations on the noradrenergic system in Alzheimer\u2019s disease","volume":"51","author":"Perry","year":"1981","journal-title":"J. Neurol. Sci."},{"issue":"5","key":"10.1016\/j.jtemb.2021.126779_bib0430","doi-asserted-by":"crossref","first-page":"379","DOI":"10.7326\/0003-4819-148-5-200803040-00009","article-title":"Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline","volume":"148","author":"Raina","year":"2008","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib0435","doi-asserted-by":"crossref","first-page":"2","DOI":"10.14283\/jpad.2018.43","article-title":"Revisiting the cholinergic hypothesis in alzheimer\u2019s disease: emerging evidence from translational and clinical research","volume":"6","author":"Hampel","year":"2019","journal-title":"J. Prev. Alzheimers Dis."},{"issue":"10","key":"10.1016\/j.jtemb.2021.126779_bib0440","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa1106668","article-title":"Donepezil and memantine for moderate-to-Severe alzheimer\u2019s disease","volume":"366","author":"Howard","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jtemb.2021.126779_bib0445","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7909380","article-title":"Is modulation of oxidative stress an answer? The state of the art of redox therapeutic actions in neurodegenerative diseases","volume":"2016","author":"Chiurchi\u00f9","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"Suppl. 1","key":"10.1016\/j.jtemb.2021.126779_bib0450","article-title":"Fatty acids and oxidative stress in psychiatric disorders","volume":"8","author":"Tsaluchidu","year":"2008","journal-title":"BMC Psychiatry"},{"issue":"14","key":"10.1016\/j.jtemb.2021.126779_bib0455","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1096\/fj.05-3735fje","article-title":"Mitochondrial A\u03b2: a potential focal point for neuronal metabolic dysfunction in Alzheimer\u2019s disease","volume":"19","author":"Caspersen","year":"2005","journal-title":"Faseb J."},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib0460","doi-asserted-by":"crossref","first-page":"621S","DOI":"10.1093\/ajcn\/71.2.621s","article-title":"Oxidative stress and Alzheimer disease","volume":"71","author":"Christen","year":"2000","journal-title":"Am. J. Clin. Nutr."},{"issue":"6","key":"10.1016\/j.jtemb.2021.126779_bib0465","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.freeradbiomed.2004.11.005","article-title":"Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations","volume":"38","author":"Liu","year":"2005","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib0470","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0197-4580(98)00009-8","article-title":"Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer\u2019s disease","volume":"19","author":"Markesbery","year":"1998","journal-title":"Neurobiol. Aging"},{"issue":"21\u201322","key":"10.1016\/j.jtemb.2021.126779_bib0475","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1016\/j.ccr.2009.05.011","article-title":"Copper, iron, and zinc ions homeostasis and their role in neurodegenerative disorders (metal uptake, transport, distribution and regulation)","volume":"253","author":"Kozlowski","year":"2009","journal-title":"Coord. Chem. Rev."},{"issue":"7","key":"10.1016\/j.jtemb.2021.126779_bib0480","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.neurobiolaging.2007.10.012","article-title":"Zinc and copper modulate Alzheimer A\u03b2 levels in human cerebrospinal fluid","volume":"30","author":"Strozyk","year":"2009","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.jtemb.2021.126779_bib0485","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0891-5849(90)90076-U","article-title":"The physiological role of zinc as an antioxidant","volume":"8","author":"Bray","year":"1990","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib0490","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40035-020-00189-z","article-title":"Current understanding of metal ions in the pathogenesis of Alzheimer\u2019s disease","volume":"9","author":"Wang","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.jtemb.2021.126779_bib0495","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/726954","article-title":"Metal dyshomeostasis and inflammation in Alzheimer\u2019s and Parkinson\u2019s diseases: possible impact of environmental exposures","author":"Myhre","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"7257","key":"10.1016\/j.jtemb.2021.126779_bib0500","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nature08300","article-title":"Metalloproteins and metal sensing","volume":"460","author":"Waldron","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jtemb.2021.126779_bib0505","first-page":"1","article-title":"Metallomics and the cell: some definitions and general comments","volume":"12","author":"Banci","year":"2013","journal-title":"Met. Ions Life Sci."},{"issue":"Suppl. 1","key":"10.1016\/j.jtemb.2021.126779_bib0510","article-title":"The metal theory of Alzheimer\u2019s disease","volume":"33","author":"Bush","year":"2013","journal-title":"J. Alzheimer Dis."},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib0515","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1073\/pnas.0809057106","article-title":"Increasing Cu bioavailability inhibits A\u03b2 oligomers and tau phosphorylation","volume":"106","author":"Crouch","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1\u20132","key":"10.1016\/j.jtemb.2021.126779_bib0520","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cbpa.2012.01.016","article-title":"Metal-associated amyloid-\u03b2 species in Alzheimer\u2019s disease","volume":"16","author":"Pithadia","year":"2012","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.jtemb.2021.126779_bib0525","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jinorgbio.2018.10.005","article-title":"Nitration of amyloid-\u03b2 peptide (1\u201342) as a protective mechanism for the amyloid-\u03b2 peptide (1\u201342) against copper ion toxicity","volume":"190","author":"Zhao","year":"2019","journal-title":"J. Inorg. Biochem."},{"issue":"11","key":"10.1016\/j.jtemb.2021.126779_bib0530","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/syn.20683","article-title":"Zinc: the brain\u2019s dark horse","volume":"63","author":"Bitanihirwe","year":"2009","journal-title":"Synapse"},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib0535","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.abb.2007.03.008","article-title":"Cellular stress and intracellular zinc dyshomeostasis","volume":"463","author":"Kr\u00f6ncke","year":"2007","journal-title":"Arch. Biochem. Biophys."},{"issue":"4","key":"10.1016\/j.jtemb.2021.126779_bib0540","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0166-2236(03)00067-5","article-title":"The metallobiology of Alzheimer\u2019s disease","volume":"26","author":"Bush","year":"2003","journal-title":"Trends Neurosci."},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib0545","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1046\/j.1471-4159.1996.66020723.x","article-title":"Zinc induced aggregation of human and rat beta amyloid peptides in vitro","volume":"66","author":"Esler","year":"1996","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.jtemb.2021.126779_bib0550","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-\u03b2 and tau: the trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol."},{"issue":"5054","key":"10.1016\/j.jtemb.2021.126779_bib0555","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: The amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.jtemb.2021.126779_bib0560","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.bbamcr.2008.11.011","article-title":"Bimodal modulation of tau protein phosphorylation and conformation by extracellular Zn2+ in human-tau transfected cells","volume":"1793","author":"Boom","year":"2009","journal-title":"Biochimica et Biophysica Acta \u2013 Mol. Cell Res."},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib0565","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cbpa.2008.02.019","article-title":"Metals in alzheimer\u2019s and parkinson\u2019s diseases","volume":"12","author":"Barnham","year":"2008","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"4","key":"10.1016\/j.jtemb.2021.126779_bib0570","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/syn.890020408","article-title":"Evidence for release of copper in the brain: Depolarization\u2010induced release of newly taken\u2010up 67copper","volume":"2","author":"Hartter","year":"1988","journal-title":"Synapse"},{"issue":"6","key":"10.1016\/j.jtemb.2021.126779_bib0575","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1111\/j.1471-4159.2009.05901.x","article-title":"Chronic copper exposure exacerbates both amyloid and tau pathology and selectively dysregulates cdk5 in a mouse model of AD","volume":"108","author":"Kitazawa","year":"2009","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.jtemb.2021.126779_bib0580","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/j.1471-4159.2009.05870.x","article-title":"Restored degradation of the Alzheimer\u2019s amyloid-\u03b2 peptide by targeting amyloid formation","volume":"108","author":"Crouch","year":"2009","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.jtemb.2021.126779_bib0585","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1471-4159.1993.tb03639.x","article-title":"Aluminum, Iron, and Zinc Ions Promote Aggregation of Physiological Concentrations of \u03b2\u2010Amyloid Peptide","volume":"61","author":"Mantyh","year":"1993","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib0590","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.neuint.2012.12.005","article-title":"Deferoxamine inhibits iron induced hippocampal tau phosphorylation in the Alzheimer transgenic mouse brain","volume":"62","author":"Guo","year":"2013","journal-title":"Neurochem. Int."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib0595","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2010.04.003","article-title":"Biological metals and Alzheimer\u2019s disease: implications for therapeutics and diagnostics","volume":"92","author":"Duce","year":"2010","journal-title":"Prog. Neurobiol."},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib0600","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1367-5931(99)00073-3","article-title":"Metals and neuroscience","volume":"4","author":"Bush","year":"2000","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"no. 5","key":"10.1016\/j.jtemb.2021.126779_bib0605","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.neuint.2012.12.006","article-title":"Metals, oxidative stress and neurodegeneration: a focus on iron, manganese and mercury","volume":"62","author":"Farina","year":"2013","journal-title":"Neurochem. Int."},{"issue":"9","key":"10.1016\/j.jtemb.2021.126779_bib0610","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1039\/B919237A","article-title":"Minding metals: tailoring multifunctional chelating agents for neurodegenerative disease","volume":"39","author":"Perez","year":"2010","journal-title":"J. Chem. Soc. Dalton Trans."},{"key":"10.1016\/j.jtemb.2021.126779_bib0615","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0074-7742(08)60279-2","article-title":"Neurobiology of zinc and zinc-containing neurons","volume":"31","author":"Frederickson","year":"1989","journal-title":"Int. Rev. Neurobiol."},{"issue":"Suppl. 2","key":"10.1016\/j.jtemb.2021.126779_bib0620","doi-asserted-by":"crossref","first-page":"14187","DOI":"10.1073\/pnas.2332818100","article-title":"Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid A\u03b2 production in APP23 transgenic mice","volume":"100","author":"Bayer","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib0625","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1523\/JNEUROSCI.3699-04.2005","article-title":"NMDA receptor activation mediates copper homeostasis in hippocampal neurons","volume":"25","author":"Schlief","year":"2005","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.jtemb.2021.126779_bib0630","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.neurobiolaging.2012.07.003","article-title":"Zinc induces protein phosphatase 2A inactivation and tau hyperphosphorylation through Src dependent PP2A (tyrosine 307) phosphorylation","volume":"34","author":"Xiong","year":"2013","journal-title":"Neurobiol. Aging"},{"issue":"10","key":"10.1016\/j.jtemb.2021.126779_bib0635","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1021\/bi0272151","article-title":"Metal binding and oxidation of amyloid-\u03b2 within isolated senile plaque cores: raman microscopic evidence","volume":"42","author":"Dong","year":"2003","journal-title":"Biochemistry"},{"issue":"46","key":"10.1016\/j.jtemb.2021.126779_bib0640","doi-asserted-by":"crossref","first-page":"27791","DOI":"10.1074\/jbc.M115.684084","article-title":"Truncated Amyloid-\u03b2 (11\u201340\/42) from alzheimer disease binds Cu 2+ with a femtomolar affinity and influences Fiber assembly","volume":"290","author":"Barritt","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.jtemb.2021.126779_bib0645","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1745-7270.2006.00228.x","article-title":"Cu(II) potentiation of Alzheimer A\u03b21-40 cytotoxicity and transition on its secondary structure","volume":"38","author":"Dai","year":"2006","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"issue":"June","key":"10.1016\/j.jtemb.2021.126779_bib0650","article-title":"The case for abandoning therapeutic chelation of copper ions in Alzheimer\u2019s disease","volume":"11","author":"Drew","year":"2017","journal-title":"Front. Neurosci."},{"issue":"21","key":"10.1016\/j.jtemb.2021.126779_bib0655","doi-asserted-by":"crossref","first-page":"12193","DOI":"10.1021\/ic4003059","article-title":"Role of metal ions in the self-assembly of the Alzheimer\u2019s amyloid-\u03b2 peptide","volume":"52","author":"Faller","year":"2013","journal-title":"Inorg. Chem."},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib0660","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s12011-012-9547-x","article-title":"Metal concentrations in cerebrospinal fluid and blood plasma from patients with amyotrophic lateral sclerosis","volume":"151","author":"Roos","year":"2013","journal-title":"Biol. Trace Elem. Res."},{"issue":"53","key":"10.1016\/j.jtemb.2021.126779_bib0665","doi-asserted-by":"crossref","first-page":"41533","DOI":"10.1074\/jbc.M110.171355","article-title":"Substoichiometric levels of Cu 2+ ions accelerate the kinetics of Fiber formation and promote cell toxicity of Amyloid-\u03b2 from alzheimer disease","volume":"285","author":"Sarell","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"32","key":"10.1016\/j.jtemb.2021.126779_bib0670","doi-asserted-by":"crossref","first-page":"9270","DOI":"10.1021\/bi700508n","article-title":"Redox reactions of copper complexes formed with different \u03b2-amyloid peptides and their neuropathalogical relevance","volume":"46","author":"Jiang","year":"2007","journal-title":"Biochemistry"},{"issue":"18","key":"10.1016\/j.jtemb.2021.126779_bib0675","doi-asserted-by":"crossref","first-page":"9024","DOI":"10.1021\/ic201233b","article-title":"Iron(II) binding to amyloid-\u03b2, the Alzheimer\u2019s peptide","volume":"50","author":"Bousejra-Elgarah","year":"2011","journal-title":"Inorg. Chem."},{"issue":"9","key":"10.1016\/j.jtemb.2021.126779_bib0680","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1523\/JNEUROSCI.5093-08.2009","article-title":"Synaptically released zinc triggers metabotropic signaling via a zinc-sensing receptor in the hippocampus","volume":"29","author":"Besser","year":"2009","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.jtemb.2021.126779_bib0685","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1177\/1073858404263463","article-title":"Zn2+ ions: modulators of excitatory and inhibitory synaptic activity","volume":"10","author":"Smart","year":"2004","journal-title":"Neuroscientist"},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib0690","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0165-0173(02)00219-9","article-title":"Zinc takes the center stage: its paradoxical role in Alzheimer\u2019s disease","volume":"41","author":"Cuajungco","year":"2003","journal-title":"Brain Res. Rev."},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib0695","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/biof.199","article-title":"A potential role for zinc alterations in the pathogenesis of Alzheimer\u2019s disease","volume":"38","author":"Lyubartseva","year":"2012","journal-title":"BioFactors"},{"issue":"5254","key":"10.1016\/j.jtemb.2021.126779_bib0700","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1126\/science.271.5254.1406","article-title":"The amyloid precursor protein of alzheimer\u2019s disease in the reduction of copper(II) to copper(I)","volume":"271","author":"Multhaup","year":"1996","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.jtemb.2021.126779_bib0705","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.cell.2017.11.014","article-title":"Structural basis for regulated proteolysis by the \u03b1-Secretase ADAM10","volume":"171","author":"Seegar","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jtemb.2021.126779_bib0710","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.exer.2014.10.012","article-title":"Iron increases APP translation and amyloid-beta production in the retina","volume":"129","author":"Guo","year":"2014","journal-title":"Exp. Eye Res."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib0715","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40035-020-00189-z","article-title":"Current understanding of metal ions in the pathogenesis of Alzheimer\u2019s disease","volume":"9","author":"Wang","year":"2020","journal-title":"Transl. Neurodegener."},{"issue":"3","key":"10.1016\/j.jtemb.2021.126779_bib0720","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/biof.1012","article-title":"Zinc in the central nervous system: from molecules to behavior","volume":"38","author":"Gower\u2010Winter","year":"2012","journal-title":"BioFactors"},{"issue":"3","key":"10.1016\/j.jtemb.2021.126779_bib0725","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1983.tb04814.x","article-title":"The Presence of Zinc\u2010Binding Proteins in Brain","volume":"41","author":"Itoh","year":"1983","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jtemb.2021.126779_bib0730","series-title":"Neurobiology of Zinc","first-page":"235","author":"Dreosti","year":"1989"},{"issue":"5","key":"10.1016\/j.jtemb.2021.126779_bib0735","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1021\/cr078203u","article-title":"Metals in neurobiology: probing their chemistry and biology with molecular imaging","volume":"108","author":"Que","year":"2008","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib0740","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0165-0270(02)00144-9","article-title":"Fluorescent zinc indicators for neurobiology","volume":"118","author":"Thompson","year":"2002","journal-title":"J. Neurosci. Methods"},{"issue":"11","key":"10.1016\/j.jtemb.2021.126779_bib0745","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nrn2734","article-title":"Zinc in the physiology and pathology of the CNS","volume":"10","author":"Sensi","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib0750","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.neuroscience.2008.01.061","article-title":"Zinc at glutamatergic synapses","volume":"158","author":"Paoletti","year":"2009","journal-title":"Neuroscience"},{"issue":"11","key":"10.1016\/j.jtemb.2021.126779_bib0755","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.3390\/ijms18112285","article-title":"Zinc in cellular regulation: the nature and significance of \u2018Zinc signals","volume":"18","author":"Maret","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.jtemb.2021.126779_bib0760","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10534-010-9406-1","article-title":"Metals on the move: zinc ions in cellular regulation and in the coordination dynamics of zinc proteins","volume":"24","author":"Maret","year":"2011","journal-title":"BioMetals"},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib0765","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1039\/c3mt00298e","article-title":"Metallothioneins (MTs) in the human eye: a perspective article on the zinc\u2013MT redox cycle","volume":"6","author":"Gonzalez-Iglesias","year":"2014","journal-title":"Metallomics"},{"issue":"7","key":"10.1016\/j.jtemb.2021.126779_bib0770","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1177\/1533317510382283","article-title":"Subclinical zinc deficiency in Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"25","author":"Brewer","year":"2010","journal-title":"Am. J. Alzheimers Dis. Other Demen."},{"issue":"6","key":"10.1016\/j.jtemb.2021.126779_bib0775","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nrn1671","article-title":"The neurobiology of zinc in health and disease","volume":"6","author":"Frederickson","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jtemb.2021.126779_bib0780","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/WNR.0b013e32834c0a2d","article-title":"Zinc stimulates tau S214 phosphorylation by the activation of Raf\/mitogenactivated protein kinase-kinase\/extracellular signal-regulated kinase pathway","volume":"22","author":"Kim","year":"2011","journal-title":"NeuroReport"},{"issue":"4","key":"10.1016\/j.jtemb.2021.126779_bib0785","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/nbdi.1999.0250","article-title":"The role of copper in neurodegenerative disease","volume":"6","author":"Waggoner","year":"1999","journal-title":"Neurobiol. Dis."},{"issue":"9","key":"10.1016\/j.jtemb.2021.126779_bib0790","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1039\/c0mt00006j","article-title":"Copper handling machinery of the brain","volume":"2","author":"Lutsenko","year":"2010","journal-title":"Metallomics"},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib0795","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00775-009-0600-y","article-title":"Copper in the brain and Alzheimer\u2019s disease","volume":"15","author":"Hung","year":"2010","journal-title":"J. Biol. Inorg. Chem."},{"issue":"4","key":"10.1016\/j.jtemb.2021.126779_bib0800","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00216-005-0264-6","article-title":"Elemental mapping and quantitative analysis of Cu, Zn and Fe in rat brain sections by laser ablation ICP-MS","volume":"384","author":"Jackson","year":"2006","journal-title":"Anal. Bioanal. Chem."},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib0805","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1385\/MN:33:2:81","article-title":"Copper homeostasis in the CNS","volume":"33","author":"Schlief","year":"2006","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jtemb.2021.126779_bib0810","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/BJ20141168","article-title":"\u201cCu2+ accentuates distinct misfolding of A\u03b2(1-40) and A\u03b2(1-42) peptides, and potentiates membrane disruption","volume":"466","author":"Matheou","year":"2015","journal-title":"Biochem. J."},{"issue":"8","key":"10.1016\/j.jtemb.2021.126779_bib0815","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.1021\/ic302289r","article-title":"Mixed ligand Cu2+ complexes of a model therapeutic with Alzheimer\u2019s amyloid-\u03b2 peptide and monoamine neurotransmitters","volume":"52","author":"Kenche","year":"2013","journal-title":"Inorg. Chem."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib0820","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1021\/tx700210j","article-title":"Oxidative stress and neurotoxicity","volume":"21","author":"Sayre","year":"2008","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jtemb.2021.126779_bib0825","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/537528","article-title":"Issues raised involving the copper hypotheses in the causation of Alzheimer\u2019s disease","author":"Brewer","year":"2011","journal-title":"Int. J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.jtemb.2021.126779_bib0830","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1021\/acs.chemrestox.6b00373","article-title":"Copper-2 hypothesis for causation of the current alzheimer\u2019s disease epidemic together with dietary changes that enhance the epidemic","volume":"30","author":"Brewer","year":"2017","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jtemb.2021.126779_bib0835","first-page":"1014","article-title":"Metal ions in alzheimer\u2019s disease brain","volume":"21","author":"Sastre","year":"2015","journal-title":"JSM Alzheimers Dis. Relat. Dement."},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib0840","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0887-8994(01)00303-4","article-title":"Iron and iron management proteins in neurobiology","volume":"25","author":"Connor","year":"2001","journal-title":"Pediatr. Neurol."},{"issue":"18","key":"10.1016\/j.jtemb.2021.126779_bib0845","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.94.18.9866","article-title":"Iron accumulation in Alzheimer disease is a source of redox-generated free radicals","volume":"94","author":"Smith","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib0850","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1471-4159.1995.64010307.x","article-title":"Iron Levels Modulate \u03b1\u2010Secretase Cleavage of Amyloid Precursor Protein","volume":"64","author":"Bodovitz","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jtemb.2021.126779_bib0855","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fphar.2014.00081","article-title":"The iron regulatory capability of the major protein participants in prevalent neurodegenerative disorders","volume":"5","author":"Wong","year":"2014","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.jtemb.2021.126779_bib0860","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1021\/cb400080f","article-title":"Untangling Amyloid-\u03b2, Tau, and metals in alzheimer\u2019s disease","volume":"8","author":"Savelieff","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jtemb.2021.126779_bib0865","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2017.00339","article-title":"Biometal dyshomeostasis and toxic metal accumulations in the development of alzheimer\u2019s disease","volume":"10","author":"Li","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jtemb.2021.126779_bib0870","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2015.00124","article-title":"Environmental pollutants as risk factors for neurodegenerative disorders: alzheimer and Parkinson diseases","volume":"9","author":"Chin-Chan","year":"2015","journal-title":"Front. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.jtemb.2021.126779_bib0875","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00702-010-0470-z","article-title":"Brain iron metabolism and its perturbation in neurological diseases","volume":"118","author":"Crichton","year":"2011","journal-title":"J. Neural Transm."},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib0880","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1476-5381.2011.01221.x","article-title":"Alzheimer\u2019s disease & metals: therapeutic opportunities","volume":"163","author":"Kenche","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.jtemb.2021.126779_bib0885","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s12017-009-8102-1","article-title":"Metal ion physiopathology in neurodegenerative disorders","volume":"11","author":"Bolognin","year":"2009","journal-title":"Neuromolecular Med."},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib0890","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cbi.2010.04.010","article-title":"The transition metals copper and iron in neurodegenerative diseases","volume":"186","author":"Rivera-Manc\u00eda","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.jtemb.2021.126779_bib0895","first-page":"1","article-title":"Metals and Alzheimer\u2019s Disease,\u201d","volume":"2011","author":"White","year":"2011","journal-title":"Int. J. Alzheimers Dis."},{"issue":"40","key":"10.1016\/j.jtemb.2021.126779_bib0900","doi-asserted-by":"crossref","first-page":"15419","DOI":"10.1074\/jbc.R118.003999","article-title":"Are N-and C-terminally truncated A\u03b2 species key pathological triggers in Alzheimer\u2019s disease?","volume":"293","author":"Dunys","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"19","key":"10.1016\/j.jtemb.2021.126779_bib0905","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1038\/emboj.2010.211","article-title":"Neurotoxicity of Alzheimer\u2019s disease A\u03b2 peptides is induced by small changes in the A\u03b242 to A\u03b240 ratio","volume":"29","author":"Kuperstein","year":"2010","journal-title":"EMBO J."},{"issue":"3","key":"10.1016\/j.jtemb.2021.126779_bib0910","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1046\/j.1471-4159.2002.00818.x","article-title":"Highly conserved and disease\u2010specific patterns of carboxyterminally truncated A\u03b2 peptides 1\u201337\/38\/39 in addition to 1\u201340\/42 in Alzheimer\u2019s disease and in patients with chronic neuroinflammation","volume":"81","author":"Wiltfang","year":"2002","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib0915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-016-0294-7","article-title":"Deposition of C-terminally truncated A\u03b2 species A\u03b237 and A\u03b239 in Alzheimer\u2019s disease and transgenic mouse models","volume":"4","author":"Reinert","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib0920","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1084\/jem.20170600","article-title":"Short A\u03b2 peptides attenuate A\u03b242 toxicity in vivo","volume":"215","author":"Moore","year":"2018","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.jtemb.2021.126779_bib0925","first-page":"145","article-title":"The functional \u03b3-secretase inhibitor prevents production of amyloid \u03b2 1\u201334 in human and murine cell lines","volume":"315","author":"Vandermeeren","year":"2001","journal-title":"a"},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib0930","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jsb.2005.09.004","article-title":"Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with \u03b2-amyloid deposits in Alzheimer\u2019s disease","volume":"155","author":"Miller","year":"2006","journal-title":"J. Struct. Biol."},{"issue":"5","key":"10.1016\/j.jtemb.2021.126779_bib0935","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2217\/fnl.11.43","article-title":"Role of amyloid-\u03b2\u2013metal interactions in Alzheimer\u2019s disease","volume":"6","author":"Duce","year":"2011","journal-title":"Future Neurol."},{"issue":"no. 1","key":"10.1016\/j.jtemb.2021.126779_bib0940","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-510X(98)00092-6","article-title":"Copper, iron and zinc in Alzheimer\u2019s disease senile plaques","volume":"158","author":"Lovell","year":"1998","journal-title":"J. Neurol. Sci."},{"issue":"s1","key":"10.1016\/j.jtemb.2021.126779_bib0945","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-2012-129017","article-title":"Metals, Membranes, and Amyloid-\u03b2 Oligomers: Key Pieces in the Alzheimer\u2019s Disease Puzzle?","volume":"33","author":"Watt","year":"2013","journal-title":"J. Alzheimer Dis."},{"issue":"3","key":"10.1016\/j.jtemb.2021.126779_bib0950","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/anie.201508597","article-title":"Free superoxide is an intermediate in the production of H2O2 by copper(I)-A\u03b2 peptide and O2","volume":"55","author":"Reybier","year":"2016","journal-title":"Angewandte Chemie"},{"key":"10.1016\/j.jtemb.2021.126779_bib0955","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.redox.2017.10.014","article-title":"Oxidative stress and the amyloid beta peptide in Alzheimer\u2019s disease","volume":"14","author":"Cheignon","year":"2018","journal-title":"Redox Biol."},{"issue":"20","key":"10.1016\/j.jtemb.2021.126779_bib0960","doi-asserted-by":"crossref","first-page":"13561","DOI":"10.1021\/acs.inorgchem.9b01399","article-title":"CuII binding properties of N-Truncated a\u03b2 peptides: in search of biological function","volume":"58","author":"Stefaniak","year":"2019","journal-title":"Inorg. Chem."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib0965","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0162-0134(98)00010-5","article-title":"Multi-metal binding site of serum albumin","volume":"70","author":"Bal","year":"1998","journal-title":"J. Inorg. Biochem."},{"issue":"32","key":"10.1016\/j.jtemb.2021.126779_bib0970","doi-asserted-by":"crossref","first-page":"8029","DOI":"10.1002\/chem.201705398","article-title":"N-terminal Cu-Binding motifs (Xxx-Zzz-His, xxx-his) and their derivatives: chemistry, biology and medicinal applications","volume":"24","author":"Gonzalez","year":"2018","journal-title":"Chem. Eur. J."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib0975","doi-asserted-by":"crossref","DOI":"10.1186\/2051-5960-1-56","article-title":"N-truncated Abeta starting with position four: early intraneuronal accumulation and rescue of toxicity using NT4X-167, a novel monoclonal antibody","volume":"2","author":"Antonios","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"issue":"6","key":"10.1016\/j.jtemb.2021.126779_bib0980","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00401-014-1287-x","article-title":"Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer\u2019s disease","volume":"127","author":"Bayer","year":"2014","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib0985","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-017-0309-z","article-title":"N-truncated A\u03b24-x peptides in sporadic Alzheimer\u2019s disease cases and transgenic Alzheimer mouse models","volume":"9","author":"Wirths","year":"2017","journal-title":"Alzheimers Res. Ther."},{"issue":"29","key":"10.1016\/j.jtemb.2021.126779_bib0990","doi-asserted-by":"crossref","first-page":"8235","DOI":"10.1002\/anie.201511968","article-title":"Resistance of Cu(A\u03b24\u201316) to copper capture by Metallothionein-3 supports a function for the A\u03b24\u201342 peptide as a synaptic CuIIScavenger","volume":"55","author":"Wezynfeld","year":"2016","journal-title":"Angewandte Chemie."},{"issue":"9","key":"10.1016\/j.jtemb.2021.126779_bib0995","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1039\/c2mt20105d","article-title":"Metallostasis and amyloid \u03b2-degrading enzymes","volume":"4","author":"Grasso","year":"2012","journal-title":"Metallomics"},{"issue":"44","key":"10.1016\/j.jtemb.2021.126779_bib1000","doi-asserted-by":"crossref","first-page":"29645","DOI":"10.1074\/jbc.R800022200","article-title":"The A\u03b2Cs of a\u03b2-cleaving proteases","volume":"283","author":"Leissring","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"April (2)","key":"10.1016\/j.jtemb.2021.126779_bib1005","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1750-3639.2008.00132.x","article-title":"Clearance of a\u03b2 from the brain in alzheimer\u2019s disease: a\u03b2-degrading enzymes in alzheimer\u2019s disease","volume":"18","author":"Miners","year":"2008","journal-title":"Brain Pathol."},{"issue":"Suppl. 1","key":"10.1016\/j.jtemb.2021.126779_bib1010","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1471-4159.2011.07510.x","article-title":"Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer\u2019s disease?","volume":"120","author":"Nalivaeva","year":"2012","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.jtemb.2021.126779_bib1015","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1523\/JNEUROSCI.4792-03.2004","article-title":"Presynaptic localization of neprilysin contributes to efficient clearance of Amyloid-\u03b2 peptide in mouse brain","volume":"24","author":"Iwata","year":"2004","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib1020","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2353\/ajpath.2007.070105","article-title":"Loss of neprilysin function promotes amyloid plaque formation and causes cerebral amyloid angiopathy","volume":"171","author":"Farris","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"27","key":"10.1016\/j.jtemb.2021.126779_bib1025","doi-asserted-by":"crossref","first-page":"24540","DOI":"10.1074\/jbc.M007579200","article-title":"Degradation of the alzheimer\u2019s amyloid \u03b2 peptide by endothelin-converting enzyme","volume":"276","author":"Eckman","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib1030","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2353\/ajpath.2009.081054","article-title":"Endothelin-converting enzyme-2 is increased in Alzheimer\u2019s disease and up-regulated by A\u03b2","volume":"175","author":"Palmer","year":"2009","journal-title":"Am. J. Pathol."},{"issue":"45","key":"10.1016\/j.jtemb.2021.126779_bib1035","doi-asserted-by":"crossref","first-page":"37644","DOI":"10.1074\/jbc.M508460200","article-title":"Amyloid \u03b2-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor","volume":"280","author":"Hemming","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.jtemb.2021.126779_bib1040","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.biotechadv.2005.01.002","article-title":"Structural features of thermozymes","volume":"23","author":"Li","year":"2005","journal-title":"Biotechnol. Adv."},{"issue":"27","key":"10.1016\/j.jtemb.2021.126779_bib1045","doi-asserted-by":"crossref","first-page":"8172","DOI":"10.1021\/bi6025962","article-title":"Metal ion activation of S-adenosylmethionine decarboxylase reflects cation charge density","volume":"46","author":"Lu","year":"2007","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.jtemb.2021.126779_bib1050","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00775-009-0467-y","article-title":"Iron binding effects on the kinetic stability and unfolding energetics of a thermophilic phenylalanine hydroxylase from Chloroflexus aurantiacus","volume":"14","author":"Pey","year":"2009","journal-title":"J. Biol. Inorg. Chem."},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib1055","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0009-8981(95)06081-N","article-title":"Effect of neurotoxic metal ions in vitro on proteolytic enzyme activities in human cerebral cortex","volume":"238","author":"Falkous","year":"1995","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib1060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2009.01.001","article-title":"Kinetic analysis of product release and metal ions in a metallonuclease","volume":"483","author":"Xie","year":"2009","journal-title":"Arch. Biochem. Biophys."},{"issue":"5","key":"10.1016\/j.jtemb.2021.126779_bib1065","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1523\/JNEUROSCI.20-05-01657.2000","article-title":"Neurons regulate extracellular levels of amyloid \u03b2-protein via proteolysis by insulin-degrading enzyme","volume":"20","author":"Vekrellis","year":"2000","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib1070","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2174\/156720508783954703","article-title":"Neprilysin and amyloid Beta peptide degradation","volume":"5","author":"Hersh","year":"2008","journal-title":"Curr. Alzheimer Res."},{"issue":"7","key":"10.1016\/j.jtemb.2021.126779_bib1075","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1073\/pnas.0230450100","article-title":"Insulin-degrading enzyme regulates the levels of insulin, amyloid \u03b2-protein, and the \u03b2-amyloid precursor protein intracellular domain in vivo","volume":"100","author":"Farris","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"11","key":"10.1016\/j.jtemb.2021.126779_bib1080","doi-asserted-by":"crossref","first-page":"6193","DOI":"10.1021\/acs.inorgchem.8b00391","article-title":"Interplay between Copper, Neprilysin, and N-Truncation of \u03b2-Amyloid","volume":"57","author":"Mital","year":"2018","journal-title":"Inorg. Chem."},{"issue":"7","key":"10.1016\/j.jtemb.2021.126779_bib1085","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.3390\/ijerph7072745","article-title":"Chelation in metal intoxication","volume":"7","author":"Flora","year":"2010","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"9","key":"10.1016\/j.jtemb.2021.126779_bib1090","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1021\/cr980453a","article-title":"Principles and recent developments in chelation treatment of metal intoxication","volume":"99","author":"Andersen","year":"1999","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jtemb.2021.126779_bib1095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ccr.2017.06.004","article-title":"The double faced role of copper in A\u03b2 homeostasis: a survey on the interrelationship between metal dyshomeostasis, UPS functioning and autophagy in neurodegeneration","volume":"347","author":"Grasso","year":"2017","journal-title":"Coord. Chem. Rev."},{"issue":"22","key":"10.1016\/j.jtemb.2021.126779_bib1100","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1021\/ja00905a001","article-title":"Hard and Soft acids and bases","volume":"85","author":"Pearson","year":"1963","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jtemb.2021.126779_bib1105","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jtemb.2014.10.001","article-title":"Chelation in metal intoxication-Principles and paradigms","volume":"31","author":"Aaseth","year":"2015","journal-title":"J. Trace Elem. Med. Biol."},{"issue":"19","key":"10.1016\/j.jtemb.2021.126779_bib1110","doi-asserted-by":"crossref","first-page":"6727","DOI":"10.1039\/C4CS00138A","article-title":"Biological metals and metal-targeting compounds in major neurodegenerative diseases","volume":"43","author":"Barnham","year":"2014","journal-title":"Chem. Soc. Rev."},{"issue":"5","key":"10.1016\/j.jtemb.2021.126779_bib1115","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1021\/acs.accounts.5b00119","article-title":"Regulation of copper and Iron homeostasis by metal chelators: a possible chemotherapy for alzheimers disease","volume":"48","author":"Robert","year":"2015","journal-title":"Acc. Chem. Res."},{"issue":"36","key":"10.1016\/j.jtemb.2021.126779_bib1120","doi-asserted-by":"crossref","first-page":"14771","DOI":"10.1073\/pnas.1302212110","article-title":"Low levels of copper disrupt brain amyloid-\u03b2 homeostasis by altering its production and clearance","volume":"110","author":"Singh","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"10","key":"10.1016\/j.jtemb.2021.126779_bib1125","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(14)70117-6","article-title":"The role of iron in brain ageing and neurodegenerative disorders","volume":"13","author":"Ward","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jtemb.2021.126779_bib1130","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jtemb.2014.12.012","article-title":"Neurodegenerative diseases and therapeutic strategies using iron chelators","volume":"31","author":"Ward","year":"2015","journal-title":"J. Trace Elem. Med. Biol."},{"key":"10.1016\/j.jtemb.2021.126779_bib1135","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.nbd.2013.09.018","article-title":"The Janus face of the heme oxygenase\/biliverdin reductase system in Alzheimer disease: It\u2019s time for reconciliation","volume":"62","author":"Barone","year":"2014","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.jtemb.2021.126779_bib1140","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1039\/c0mt00068j","article-title":"The role of His-50 of \u03b1-synuclein in binding Cu(ii): pH dependence, speciation, thermodynamics and structure","volume":"3","author":"Valensin","year":"2011","journal-title":"Metallomics"},{"issue":"3","key":"10.1016\/j.jtemb.2021.126779_bib1145","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1023\/A:1009252919854","article-title":"Iron and activated oxygen species in biology: the basic chemistry","volume":"12","author":"Pierre","year":"1999","journal-title":"BioMetals"},{"issue":"12","key":"10.1016\/j.jtemb.2021.126779_bib1150","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1351\/pac200779122325","article-title":"Fenton chemistry in biology and medicine","volume":"79","author":"Prousek","year":"2007","journal-title":"Pure Appl. Chem."},{"key":"10.1016\/j.jtemb.2021.126779_bib1155","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1196\/annals.1306.026","article-title":"Novel chelators for central nervous system disorders that involve alterations in the metabolism of iron and other metal ions","volume":"1012","author":"Richardson","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.jtemb.2021.126779_bib1160","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1124\/pr.57.4.2","article-title":"The evolution of Iron chelators for the treatment of Iron overload disease and Cancer","volume":"57","author":"Kalinowski","year":"2005","journal-title":"Pharmacol. Rev."},{"issue":"9369","key":"10.1016\/j.jtemb.2021.126779_bib1165","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(03)13309-0","article-title":"Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial","volume":"361","author":"Nisbet-Brown","year":"2003","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.jtemb.2021.126779_bib1170","first-page":"873","article-title":"Randomized phase II trial of deferasirox (Exjade\u2022, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload","volume":"91","author":"Piga","year":"2006","journal-title":"Haematologica"},{"issue":"S28","key":"10.1016\/j.jtemb.2021.126779_bib1175","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3109\/03009747909108228","article-title":"Some aspects of the mechanism of action of penicillamine in rheumatoid arthritis","volume":"8","author":"Munthe","year":"1979","journal-title":"Scand. J. Rheumatol."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib1180","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1067\/mhj.2000.107548","article-title":"Chelation therapy for coronary heart disease: an overview of all clinical investigations","volume":"140","author":"Ernst","year":"2000","journal-title":"Am. Heart J."},{"issue":"4","key":"10.1016\/j.jtemb.2021.126779_bib1185","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jama.287.4.481","article-title":"Chelation therapy for ischemic heart disease","volume":"287","author":"Knudtson","year":"2002","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib1190","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0300-483X(92)90105-N","article-title":"Depletion of essential elements by calcium disodium EDTA treatment in the dog","volume":"73","author":"Ibim","year":"1992","journal-title":"Toxicology"},{"key":"10.1016\/j.jtemb.2021.126779_bib1195","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ica.2017.11.029","article-title":"Azo-dyes based small bifunctional molecules for metal chelation and controlling amyloid formation","volume":"471","author":"Rana","year":"2018","journal-title":"Inorganica Chim. Acta"},{"issue":"12","key":"10.1016\/j.jtemb.2021.126779_bib1200","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23123100","article-title":"Preparation of 4-flexible amino-2-arylethenyl-quinoline derivatives as multi-target agents for the treatment of Alzheimer\u2019s disease","volume":"23","author":"Wang","year":"2018","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.jtemb.2021.126779_bib1205","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd1330","article-title":"Neurodegenerative diseases and oxidative stress","volume":"3","author":"Barnham","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib1210","article-title":"Metal protein attenuating compounds for the treatment of Alzheimer\u2019s dementia","volume":"2014","author":"Sampson","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jtemb.2021.126779_bib1215","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2147\/DDDT.S49763","article-title":"8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications","volume":"7","author":"Prachayasittikul","year":"2013","journal-title":"Drug Des. Devel. Ther."},{"issue":"3","key":"10.1016\/j.jtemb.2021.126779_bib1220","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jinorgbio.2010.08.014","article-title":"Hydroxyquinoline based binders: Promising ligands for chelatotherapy?","volume":"105","author":"Budimir","year":"2011","journal-title":"J. Inorg. Biochem."},{"issue":"5","key":"10.1016\/j.jtemb.2021.126779_bib1225","doi-asserted-by":"crossref","first-page":"494","DOI":"10.2174\/1567205011310050005","article-title":"Efficacy and toxicity of clioquinol treatment and A-beta42 inoculation in the APP\/PSI mouse model of alzheimer\u2019s disease","volume":"10","author":"Zhang","year":"2013","journal-title":"Curr. Alzheimer Res."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib1230","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuron.2008.06.018","article-title":"Rapid restoration of cognition in alzheimer\u2019s transgenic mice with 8-Hydroxy quinoline analogs is associated with decreased interstitial a\u03b2","volume":"59","author":"Adlard","year":"2008","journal-title":"Neuron"},{"issue":"November","key":"10.1016\/j.jtemb.2021.126779_bib1235","article-title":"Advances in multi-functional ligands and the need for metal-related pharmacology for the management of Alzheimer disease","volume":"9","author":"Sharma","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"21","key":"10.1016\/j.jtemb.2021.126779_bib1240","doi-asserted-by":"crossref","first-page":"10724","DOI":"10.1021\/ic2012205","article-title":"Development of bifunctional stilbene derivatives for targeting and modulating metal-amyloid-\u03b2 species","volume":"50","author":"Braymer","year":"2011","journal-title":"Inorg. Chem."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib1245","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1039\/C4MT00252K","article-title":"Modulation of the A\u03b2 peptide aggregation pathway by KP1019 limits A\u03b2-associated neurotoxicity","volume":"7","author":"Jones","year":"2015","journal-title":"Metallomics"},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib1250","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1039\/C4MT00167B","article-title":"Thioflavin-based molecular probes for application in Alzheimer\u2019s disease: from in silico to in vitro models","volume":"7","author":"Rodr\u00edguez-Rodr\u00edguez","year":"2015","journal-title":"Metallomics"},{"issue":"no. 18","key":"10.1016\/j.jtemb.2021.126779_bib1255","doi-asserted-by":"crossref","first-page":"4830","DOI":"10.1039\/c1dt00020a","article-title":"The chelation targeting metal-A\u03b240 aggregates may lead to formation of A\u03b240 oligomers","volume":"40","author":"Zhang","year":"2011","journal-title":"J. Chem. Soc. Dalton Trans."},{"issue":"21","key":"10.1016\/j.jtemb.2021.126779_bib1260","doi-asserted-by":"crossref","first-page":"9146","DOI":"10.1021\/jm3003813","article-title":"Liberation of copper from amyloid plaques: making a risk factor useful for alzheimers disease treatment","volume":"55","author":"Geng","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jtemb.2021.126779_bib1265","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejmech.2013.10.068","article-title":"Design, synthesis and biological evaluation of imine resveratrol derivatives as multi-targeted agents against Alzheimer\u2019s disease","volume":"71","author":"Li","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jtemb.2021.126779_bib1270","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ejmech.2016.12.045","article-title":"Synthesis and biological evaluation of deferiprone-resveratrol hybrids as antioxidants, A\u03b21\u201342aggregation inhibitors and metal-chelating agents for Alzheimer\u2019s disease","volume":"127","author":"Xu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.jtemb.2021.126779_bib1275","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.bmcl.2014.12.034","article-title":"Multifunctional coumarin derivatives: monoamine oxidase B (MAO-B) inhibition, anti-\u03b2-amyloid (A\u03b2) aggregation and metal chelation properties against Alzheimer\u2019s disease","volume":"25","author":"Huang","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"17","key":"10.1016\/j.jtemb.2021.126779_bib1280","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1016\/j.bmc.2014.06.057","article-title":"Syntheses of coumarin\u2013tacrine hybrids as dual-site acetylcholinesterase inhibitors and their activity against butylcholinesterase, A\u03b2 aggregation, and \u03b2-secretase","volume":"22","author":"Sun","year":"2014","journal-title":"Bioorg. Med. Chem."},{"issue":"13","key":"10.1016\/j.jtemb.2021.126779_bib1285","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1016\/j.bmc.2015.04.009","article-title":"Synthesis and evaluation of selegiline derivatives as monoamine oxidase inhibitor, antioxidant and metal chelator against Alzheimer\u2019s disease","volume":"23","author":"Xie","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"20","key":"10.1016\/j.jtemb.2021.126779_bib1290","doi-asserted-by":"crossref","first-page":"6097","DOI":"10.1021\/ja00514a037","article-title":"Coordination chemistry of microbial Iron transport compounds. 19. Stability constants and electrochemical behavior of ferric enterobactin and model complexes","volume":"101","author":"Harris","year":"1979","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jtemb.2021.126779_bib1295","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jinorgbio.2017.03.003","article-title":"New tris(dopamine) derivative as an iron chelator. Synthesis, solution thermodynamic stability, and antioxidant research","volume":"171","author":"Zhang","year":"2017","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jtemb.2021.126779_bib1300","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.poly.2018.12.053","article-title":"New hexadentate tris(dopamine) as iron chelating agent: synthesis, solution thermodynamic stability and antioxidant activity studies","volume":"160","author":"Zhang","year":"2019","journal-title":"Polyhedron"},{"issue":"5","key":"10.1016\/j.jtemb.2021.126779_bib1305","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1021\/bi051815t","article-title":"Spectral, kinetic, and thermodynamic properties of Cu(I) and Cu(II) binding by Methanobactin from Methylosinus trichosporium OB3b \u2020","volume":"45","author":"Choi","year":"2006","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.jtemb.2021.126779_bib1310","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1021\/ic101965j","article-title":"Copper-binding properties and structures of methanobactins from Methylosinus trichosporium OB3b","volume":"50","author":"El Ghazouani","year":"2011","journal-title":"Inorg. Chem."},{"issue":"6","key":"10.1016\/j.jtemb.2021.126779_bib1315","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1128\/AEM.03884-15","article-title":"A TonB-Dependent transporter is responsible for methanobactin uptake by Methylosinus trichosporium OB3b","volume":"82","author":"Gu","year":"2016","journal-title":"Appl. Environ. Microbiol."},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib1320","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1021\/cb2003913","article-title":"Chemistry and biology of the copper Chelator methanobactin","volume":"7","author":"Kenney","year":"2012","journal-title":"ACS Chem. Biol."},{"issue":"7","key":"10.1016\/j.jtemb.2021.126779_bib1325","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1172\/JCI85226","article-title":"Methanobactin reverses acute liver failure in a rat model of Wilson disease","volume":"126","author":"Lichtmannegger","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.jtemb.2021.126779_bib1330","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1039\/C9NP00058E","article-title":"Metal binding ability of microbial natural metal chelators and potential applications","volume":"37","author":"Hofmann","year":"2020","journal-title":"Nat. Prod. Rep."},{"issue":"12","key":"10.1016\/j.jtemb.2021.126779_bib1335","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1007\/s13361-017-1778-9","article-title":"Binding selectivity of Methanobactin from Methylosinus trichosporium OB3b for copper(I), silver(I), zinc(II), nickel(II), cobalt(II), manganese(II), lead(II), and Iron(II)","volume":"28","author":"McCabe","year":"2017","journal-title":"J. Am. Soc. Mass Spectrom."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib1340","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jtemb.2010.12.002","article-title":"The biogenic methanobactin is an effective chelator for copper in a rat model for Wilson disease","volume":"25","author":"Summer","year":"2011","journal-title":"J. Trace Elem. Med. Biol."},{"issue":"5","key":"10.1016\/j.jtemb.2021.126779_bib1345","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/ana.23648","article-title":"The blood-brain barrier in health and disease","volume":"72","author":"Daneman","year":"2012","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib1350","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","article-title":"The blood-brain barrier in health and chronic neurodegenerative disorders","volume":"57","author":"Zlokovic","year":"2008","journal-title":"Neuron"},{"issue":"9","key":"10.1016\/j.jtemb.2021.126779_bib1355","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.2174\/1568026614666140329230311","article-title":"Recent advances in delivery through the blood-brain barrier","volume":"14","author":"Larsen","year":"2014","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.jtemb.2021.126779_bib1360","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1039\/b815404j","article-title":"Altering pyridinone N-substituents to optimise activity as potential prodrugs for Alzheimer\u2019s disease","volume":"45","author":"Scott","year":"2008","journal-title":"J. Chem. Soc. Dalton Trans."},{"issue":"23","key":"10.1016\/j.jtemb.2021.126779_bib1365","doi-asserted-by":"crossref","first-page":"7453","DOI":"10.1021\/ja068965r","article-title":"Synthesis, characterization, and metal coordinating ability of multifunctional carbohydrate-containing compounds for Alzheimer\u2019s therapy","volume":"129","author":"Storr","year":"2007","journal-title":"J. Am. Chem. Soc."},{"issue":"16","key":"10.1016\/j.jtemb.2021.126779_bib1370","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1039\/b902545f","article-title":"Glycosylated tetrahydrosalens as multifunctional molecules for Alzheimer\u2019s therapy","author":"Storr","year":"2009","journal-title":"J. Chem. Soc. Dalton Trans."},{"issue":"6","key":"10.1016\/j.jtemb.2021.126779_bib1375","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1039\/b514859f","article-title":"Design of targeting ligands in medicinal inorganic chemistry","volume":"35","author":"Storr","year":"2006","journal-title":"Chem. Soc. Rev."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib1380","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1021\/jm070800l","article-title":"A novel iron-chelating derivative of the neuroprotective peptide NAPVSIPQ shows superior antioxidant and antineurodegenerative capabilities","volume":"51","author":"Blat","year":"2008","journal-title":"J. Med. Chem."},{"issue":"71","key":"10.1016\/j.jtemb.2021.126779_bib1385","first-page":"163","article-title":"Novel neuroprotective neurotrophic NAP analogs targeting metal toxicity and oxidative stress: potential candidates for the control of neurodegenerative diseases","author":"Zheng","year":"2006","journal-title":"J. Neural Transm."},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib1390","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ejpb.2004.07.009","article-title":"Novel D-penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer\u2019s and other CNS diseases","volume":"59","author":"Cui","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"8","key":"10.1016\/j.jtemb.2021.126779_bib1395","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/j.bmc.2009.02.043","article-title":"Nanoparticles in cellular drug delivery","volume":"17","author":"Faraji","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jtemb.2021.126779_bib1400","series-title":"Metal-based Neurodegeneration: From Molecular Mechanisms to Therapeutic Strategies","author":"Crichton","year":"2006"},{"issue":"43","key":"10.1016\/j.jtemb.2021.126779_bib1405","doi-asserted-by":"crossref","first-page":"12666","DOI":"10.1021\/ja027013s","article-title":"Synthesis and evaluation of iron chelators with masked hydrophilic moieties","volume":"124","author":"Meijler","year":"2002","journal-title":"J. Am. Chem. Soc."},{"issue":"10\u201311","key":"10.1016\/j.jtemb.2021.126779_bib1410","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.ccr.2007.10.019","article-title":"Metal based neurodegenerative diseases\u2014from molecular mechanisms to therapeutic strategies","volume":"252","author":"Crichton","year":"2008","journal-title":"Coord. Chem. Rev."},{"issue":"15","key":"10.1016\/j.jtemb.2021.126779_bib1415","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1039\/b507385p","article-title":"Synthesis and biological evaluation of lipophilic iron chelators as protective agents from oxidative stress","volume":"3","author":"Yavin","year":"2005","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.jtemb.2021.126779_bib1420","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2019.00180","article-title":"Iron in neurodegeneration \u2013 cause or consequence?","volume":"13","author":"Ndayisaba","year":"2019","journal-title":"Front. Neurosci."},{"issue":"7","key":"10.1016\/j.jtemb.2021.126779_bib1425","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3390\/biom9070269","article-title":"Metal chelation therapy and parkinson\u2019s disease: a critical review on the thermodynamics of complex formation between relevant metal ions and promising or established drugs","volume":"9","author":"Tosato","year":"2019","journal-title":"Biomolecules"},{"issue":"10","key":"10.1016\/j.jtemb.2021.126779_bib1430","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1039\/C7MT00244K","article-title":"Subcellular compartmentalisation of copper, iron, manganese, and zinc in the Parkinson\u2019s disease brain","volume":"9","author":"Genoud","year":"2017","journal-title":"Metallomics"},{"issue":"3","key":"10.1016\/j.jtemb.2021.126779_bib1435","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1021\/acs.molpharmaceut.7b00841","article-title":"The pivotal role of copper in neurodegeneration: a new strategy for the therapy of neurodegenerative disorders","volume":"15","author":"Giampietro","year":"2018","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib1440","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1021\/acs.chemrev.8b00138","article-title":"Development of multifunctional molecules as potential therapeutic candidates for Alzheimer\u2019s disease, Parkinson\u2019s disease, and amyotrophic lateral sclerosis in the last decade","volume":"119","author":"Savelieff","year":"2018","journal-title":"Chem. Rev."},{"issue":"8753","key":"10.1016\/j.jtemb.2021.126779_bib1445","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/0140-6736(91)92978-B","article-title":"Intramuscular desferrioxamine in patients with Alzheimer\u2019s disease","volume":"337","author":"McLachlan","year":"1991","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.jtemb.2021.126779_bib1450","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1474-4422(08)70167-4","article-title":"Safety, efficacy, and biomarker findings of PBT2 in targeting A\u03b2 as a modifying therapy for Alzheimer\u2019s disease: a phase IIa, double-blind, randomised, placebo-controlled trial","volume":"7","author":"Lannfelt","year":"2008","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.jtemb.2021.126779_bib1455","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1517\/14740338.6.3.235","article-title":"Deferasirox: uncertain future following renal failure fatalities, agranulocytosis and other toxicities","volume":"6","author":"Kontoghiorghes","year":"2007","journal-title":"Expert Opin. Drug Saf."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib1460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/15376516.2012.720305","article-title":"The Proceedings of the 20th International Conference on Chelation held in the USA: advances on new and old chelation therapies","volume":"23","author":"Kontoghiorghes","year":"2013","journal-title":"Toxicol. Mech. Methods"},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib1465","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1517\/14740330903535845","article-title":"Safety issues of iron chelation therapy in patients with normal range iron stores including thalassaemia, neurodegenerative, renal and infectious diseases","volume":"9","author":"Kontoghiorghes","year":"2010","journal-title":"Expert Opin. Drug Saf."},{"issue":"12","key":"10.1016\/j.jtemb.2021.126779_bib1470","doi-asserted-by":"crossref","first-page":"e82662","DOI":"10.1371\/journal.pone.0082662","article-title":"Comparative efficacy and safety of Deferoxamine, Deferiprone and Deferasirox on severe thalassemia: a meta-analysis of 16 randomized controlled trials","volume":"8","author":"Xia","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jtemb.2021.126779_bib1475","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.freeradbiomed.2013.01.017","article-title":"Targeting dysregulation of brain iron homeostasis in Parkinson\u2019s disease by iron chelators","volume":"62","author":"Weinreb","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"8","key":"10.1016\/j.jtemb.2021.126779_bib1480","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1089\/ars.2012.4540","article-title":"Novel chelators for cancer treatment: Where are we now?","volume":"18","author":"Merlot","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.jtemb.2021.126779_bib1485","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.biopha.2018.12.140","article-title":"An attempt to elucidate the role of iron and zinc ions in development of Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"111","author":"Wojtunik-Kulesza","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib1490","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1755-5949.2010.00231.x","article-title":"Clioquinol: review of its mechanisms of action and clinical uses in neurodegenerative Disorders","volume":"18","author":"Bareggi","year":"2012","journal-title":"CNS Neurosci. Ther."},{"issue":"33","key":"10.1016\/j.jtemb.2021.126779_bib1495","doi-asserted-by":"crossref","first-page":"23223","DOI":"10.1074\/jbc.274.33.23223","article-title":"Aqueous dissolution of Alzheimer\u2019s disease A\u03b2 amyloid deposits by biometal depletion","volume":"274","author":"Cherny","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.jtemb.2021.126779_bib1500","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1002\/cbic.200500220","article-title":"Preparation of cyclo-phen-type ligands: chelators of metal ions as potential therapeutic agents in the treatment of neurodegenerative diseases","volume":"6","author":"Boldron","year":"2005","journal-title":"Chem. Bio. Chem."},{"issue":"11\u201312","key":"10.1016\/j.jtemb.2021.126779_bib1505","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.exger.2004.08.016","article-title":"Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer\u2019s amyloidogenesis","volume":"39","author":"Dedeoglu","year":"2004","journal-title":"Exp. Gerontol."},{"issue":"10","key":"10.1016\/j.jtemb.2021.126779_bib1510","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.neurobiolaging.2004.01.005","article-title":"The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human \u03b2-amyloid precursor protein transgenic mice","volume":"25","author":"Lee","year":"2004","journal-title":"Neurobiol. Aging"},{"issue":"12","key":"10.1016\/j.jtemb.2021.126779_bib1515","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1016\/j.bmcl.2006.03.026","article-title":"1,1\u2032-Xylyl bis-1,4,8,11-tetraaza cyclotetradecane: A new potential copper chelator agent for neuroprotection in Alzheimer\u2019s disease. Its comparative effects with clioquinol on rat brain copper distribution","volume":"16","author":"Moret","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib1520","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bbr.2010.09.027","article-title":"Quercetin and rutin prevent scopolamine-induced memory impairment in zebrafish","volume":"217","author":"Richetti","year":"2011","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib1525","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031211","article-title":"Curcumin enhances neurogenesis and cognition in aged rats: implications for transcriptional interactions related to growth and synaptic plasticity","volume":"7","author":"Dong","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib1530","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3233\/NUA-2012-0003","article-title":"Targeting dysregulation of brain iron homeostasis in ageing","volume":"1","author":"Weinreb","year":"2012","journal-title":"Nutr. Aging"},{"issue":"9","key":"10.1016\/j.jtemb.2021.126779_bib1535","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0024-3205(97)00592-4","article-title":"Metabolism of administered triethylene tetramine dihydrochloride in humans","volume":"61","author":"Kodama","year":"1997","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib1540","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1620\/tjem.169.59","article-title":"Fate of orally administered triethylenetetramine dihydrochloride: a therapeutic drug for Wilson\u2019s disease","volume":"169","author":"Kodama","year":"1993","journal-title":"Tohoku J. Exp. Med."},{"issue":"17","key":"10.1016\/j.jtemb.2021.126779_bib1545","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.2174\/092986712800609689","article-title":"Chelating agents for neurodegenerative diseases","volume":"19","author":"Ward","year":"2012","journal-title":"Curr. Med. Chem."},{"issue":"S2","key":"10.1016\/j.jtemb.2021.126779_bib1550","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2019.03.18","article-title":"Clinical management of Wilson disease","volume":"7","author":"Hedera","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.jtemb.2021.126779_bib1555","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jtemb.2019.05.003","article-title":"Heavy metal toxicity: an update of chelating therapeutic strategies","volume":"54","author":"Kim","year":"2019","journal-title":"J. Trace Elem. Med. Biol."},{"key":"10.1016\/j.jtemb.2021.126779_bib1560","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.toxrep.2020.01.015","article-title":"Curcumin attenuates copper-induced oxidative stress and neurotoxicity in Drosophila melanogaster","volume":"7","author":"Abolaji","year":"2020","journal-title":"Toxicol. Rep."},{"issue":"9","key":"10.1016\/j.jtemb.2021.126779_bib1565","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.biocel.2008.01.021","article-title":"Expression and localisation of the essential copper transporter DmATP7 in Drosophila neuronal and intestinal tissues","volume":"40","author":"Burke","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jtemb.2021.126779_bib1570","doi-asserted-by":"crossref","first-page":"125428","DOI":"10.1016\/j.chemosphere.2019.125428","article-title":"Oxidative stress caused by lead (Pb) induces iron deficiency in Drosophila melanogaster","volume":"243","author":"Liu","year":"2020","journal-title":"Chemosphere"},{"key":"10.1016\/j.jtemb.2021.126779_bib1575","doi-asserted-by":"crossref","first-page":"125533","DOI":"10.1016\/j.chemosphere.2019.125533","article-title":"Multigenerational effects of cadmium on the lifespan and fertility of Drosophila melanogaster","volume":"245","author":"Yang","year":"2020","journal-title":"Chemosphere"},{"key":"10.1016\/j.jtemb.2021.126779_bib1580","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2019.135306","article-title":"Copper decreases associative learning and memory in Drosophila melanogaster","volume":"710","author":"Zamberlan","year":"2020","journal-title":"Sci. Total Environ."},{"issue":"December","key":"10.1016\/j.jtemb.2021.126779_bib1585","article-title":"Copper and zinc homeostasis: Lessons from Drosophila melanogaster","volume":"8","author":"Navarro","year":"2017","journal-title":"Front. Genet."},{"issue":"6","key":"10.1016\/j.jtemb.2021.126779_bib1590","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s10534-011-9463-0","article-title":"Acute and chronic metal exposure impairs locomotion activity in Drosophila melanogaster: a model to study Parkinsonism","volume":"24","author":"Bonilla-Ramirez","year":"2011","journal-title":"BioMetals"},{"key":"10.1016\/j.jtemb.2021.126779_bib1595","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/567128","article-title":"Neuroprotective role of a novel copper Chelator against a\u03b2-induced neurotoxicity","volume":"2013","author":"Singh","year":"2013","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.jtemb.2021.126779_bib1600","doi-asserted-by":"crossref","DOI":"10.1093\/toxres\/tfaa032","article-title":"D-Penicillamine prolongs survival and lessens copper-induced toxicity in Drosophila melanogaster","author":"Abolaji","year":"2020","journal-title":"Toxicol. Res. (Camb)"},{"issue":"6","key":"10.1016\/j.jtemb.2021.126779_bib1605","article-title":"Biogenesis of zinc storage granules in Drosophila melanogaster","volume":"221","author":"Tejeda-Guzm\u00e1n","year":"2018","journal-title":"J. Exp. Biol."},{"issue":"7","key":"10.1016\/j.jtemb.2021.126779_bib1610","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118705","article-title":"Cellular iron sensing and regulation: nuclear IRP1 extends a classic paradigm","volume":"1867","author":"Hern\u00e1ndez-Gallardo","year":"2020","journal-title":"Biochimica et Biophysica Acta - Molecular Cell Research"},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib1615","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1039\/c9mt00218a","article-title":"Intestinal response to dietary manganese depletion in Drosophila","volume":"12","author":"V\u00e1squez-Procopio","year":"2020","journal-title":"Metallomics"},{"issue":"4","key":"10.1016\/j.jtemb.2021.126779_bib1620","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1089\/dna.1.1989.8.233","article-title":"Characterization of the hsp70 multigene family of Caenorhabditis elegans","volume":"8","author":"Heschl","year":"1989","journal-title":"DNA"},{"issue":"3","key":"10.1016\/j.jtemb.2021.126779_bib1625","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1039\/c0mt00064g","article-title":"Insights from Caenorhabditis elegans on the role of metals in neurodegenerative diseases","volume":"3","author":"Martinez-Finley","year":"2011","journal-title":"Metallomics"},{"issue":"7","key":"10.1016\/j.jtemb.2021.126779_bib1630","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph15071407","article-title":"C. Elegans\u2014an emerging model to study metal-induced rage-related pathologies","volume":"15","author":"Pinkas","year":"2018","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"12","key":"10.1016\/j.jtemb.2021.126779_bib1635","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/biot.201000183","article-title":"Modeling human diseases in Caenorhabditis elegans","volume":"5","author":"Markaki","year":"2010","journal-title":"Biotechnol. J."},{"issue":"3","key":"10.1016\/j.jtemb.2021.126779_bib1640","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ecoenv.2006.02.017","article-title":"Shortened lifespan of nematode Caenorhabditis elegans after prolonged exposure to heavy metals and detergents","volume":"66","author":"Harada","year":"2007","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib1645","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/toxsci\/kfn180","article-title":"Knock down of caenorhabditis elegans cutc-1 exacerbates the sensitivity toward high levels of copper","volume":"106","author":"Calafato","year":"2008","journal-title":"Toxicol. Sci."},{"issue":"51","key":"10.1016\/j.jtemb.2021.126779_bib1650","doi-asserted-by":"crossref","first-page":"35758","DOI":"10.1074\/jbc.M109.051409","article-title":"The divalent metal transporter homologues SMF-1\/2 mediate dopamine neuron sensitivity in Caenorhabditis elegans models of manganism and parkinson disease","volume":"284","author":"Settivari","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.jtemb.2021.126779_bib1655","doi-asserted-by":"crossref","first-page":"e1001084","DOI":"10.1371\/journal.pgen.1001084","article-title":"Extracellular dopamine potentiates Mn-Induced oxidative stress, lifespan reduction, and dopaminergic neurodegeneration in a BLI-3\u2013Dependent manner in Caenorhabditis elegans","volume":"6","author":"Benedetto","year":"2010","journal-title":"PLoS Genet."},{"issue":"6","key":"10.1016\/j.jtemb.2021.126779_bib1660","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s11427-011-4180-z","article-title":"Copper ions influence the toxicity of \u03b2-amyloid(1-42) in a concentration-dependent manner in a Caenorhabditis elegans model of Alzheimer\u2019s disease","volume":"54","author":"Luo","year":"2011","journal-title":"Sci. China Life Sci."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib1665","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.freeradbiomed.2010.10.707","article-title":"\u03b2-Amyloid peptide increases levels of iron content and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease","volume":"50","author":"Wan","year":"2011","journal-title":"Free Radic. Biol. Med."},{"issue":"5","key":"10.1016\/j.jtemb.2021.126779_bib1670","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1039\/c2mt00146b","article-title":"Aluminium exposure disrupts elemental homeostasis in Caenorhabditis elegans","volume":"4","author":"Page","year":"2012","journal-title":"Metallomics"},{"issue":"3","key":"10.1016\/j.jtemb.2021.126779_bib1675","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1177\/0960327110392084","article-title":"The Caenorhabiditis elegans model as a reliable tool in neurotoxicology","volume":"31","author":"Avila","year":"2012","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.jtemb.2021.126779_bib1680","article-title":"Metal-induced neurodegeneration in C. Elegans","volume":"5","author":"Aschner","year":"2013","journal-title":"Front. Aging Neurosci."},{"issue":"11","key":"10.1016\/j.jtemb.2021.126779_bib1685","doi-asserted-by":"crossref","first-page":"975","DOI":"10.18632\/aging.100689","article-title":"Iron promotes protein insolubility and aging in C. Elegans","volume":"6","author":"Klang","year":"2014","journal-title":"Aging"},{"issue":"4","key":"10.1016\/j.jtemb.2021.126779_bib1690","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153513","article-title":"Zinc levels modulate lifespan through multiple longevity pathways in caenorhabditis elegans","volume":"11","author":"Kumar","year":"2016","journal-title":"PLoS One"},{"issue":"no. 5","key":"10.1016\/j.jtemb.2021.126779_bib1695","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/etc.5620220518","article-title":"Availability of metals to the nematode Caenorhabditis elegans : toxicity based on total concentrations in soil and extracted fractions","volume":"22","author":"Boyd","year":"2003","journal-title":"Environ. Toxicol. Chem."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib1700","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/toxsci\/kfn121","article-title":"Caenorhabditis elegans: an emerging model in biomedical and environmental toxicology \u2014 albert Einstein College of Medicine","volume":"106","author":"Leung","year":"2008","journal-title":"Toxicol. Sci."},{"issue":"13","key":"10.1016\/j.jtemb.2021.126779_bib1705","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1007\/s00018-005-5073-8","article-title":"Copper and zinc dismetabolism in the mouse brain upon chronic cuprizone treatment","volume":"62","author":"Zatta","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.jtemb.2021.126779_bib1710","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3233\/JAD-2009-1068","article-title":"Challenges associated with metal chelation therapy in alzheimer\u2019s disease","volume":"17","author":"Hegde","year":"2009","journal-title":"J. Alzheimer Dis."},{"issue":"21","key":"10.1016\/j.jtemb.2021.126779_bib1715","doi-asserted-by":"crossref","first-page":"12817","DOI":"10.1074\/jbc.273.21.12817","article-title":"Dramatic aggregation of alzheimer by Cu(II) is induced by conditions representing physiological acidosis","volume":"273","author":"Atwood","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.jtemb.2021.126779_bib1720","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1007\/s00018-005-5141-0","article-title":"Aluminum-triggered structural modifications and aggregation of \u03b2-amyloids","volume":"62","author":"Ricchelli","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib1725","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/187152712799960709","article-title":"Nanoparticle delivery of transition-metal chelators to the brain: Oxidative stress will never see it coming!","volume":"11","author":"Bonda","year":"2012","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib1730","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0169-409X(00)00122-8","article-title":"Nanoparticulate systems for brain delivery of drugs","volume":"47","author":"Kreuter","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.jtemb.2021.126779_bib1735","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neulet.2006.07.020","article-title":"Nanoparticle iron chelators: a new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance","volume":"406","author":"Liu","year":"2006","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.jtemb.2021.126779_bib1740","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.bbadis.2005.06.006","article-title":"Nanoparticle and other metal chelation therapeutics in Alzheimer disease","volume":"1741","author":"Liu","year":"2005","journal-title":"Biochimica et Biophysica Acta - Molecular Basis of Disease"},{"key":"10.1016\/j.jtemb.2021.126779_bib1745","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.brainres.2008.01.039","article-title":"Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer\u2019s disease","volume":"1200","author":"Wilson","year":"2008","journal-title":"Brain Res."},{"issue":"11","key":"10.1016\/j.jtemb.2021.126779_bib1750","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1021\/js980084y","article-title":"Nanoparticle technology for delivery of drugs across the blood\u2013Brain barrier","volume":"87","author":"Schroeder","year":"1998","journal-title":"J. Pharm. Sci."},{"issue":"8\u20139","key":"10.1016\/j.jtemb.2021.126779_bib1755","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.progpolymsci.2007.05.014","article-title":"Nanomedicine in the diagnosis and therapy of neurodegenerative disorders","volume":"32","author":"Kabanov","year":"2007","journal-title":"Progress in Polymer Science (Oxford)"},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib1760","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev.med.60.041807.123243","article-title":"Oral Iron chelators","volume":"60","author":"Cappellini","year":"2009","journal-title":"Annu. Rev. Med."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib1765","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/blood-2002-06-1867","article-title":"Role of deferiprone in chelation therapy for transfusional iron overload","volume":"102","author":"Hoffbrand","year":"2003","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jtemb.2021.126779_bib1770","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V108.11.1768.1768","article-title":"Long-term safety and tolerability of the once-daily, oral Iron Chelator deferasirox (Exjade\u00ae, ICL670) in patients with transfusional Iron overload","volume":"108","author":"Cappellini","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib1775","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/1389557043487583","article-title":"Chemical and biological considerations in the treatment of metal intoxications by chelating agents","volume":"4","author":"Andersen","year":"2004","journal-title":"Mini-Reviews Med. Chem."},{"issue":"10","key":"10.1016\/j.jtemb.2021.126779_bib1780","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.2165\/11591370-000000000-00000","article-title":"Therapeutic potential of copper chelation with triethylenetetramine in managing diabetes mellitus and alzheimer\u02bcs disease","volume":"71","author":"Cooper","year":"2011","journal-title":"Drugs"},{"issue":"8","key":"10.1016\/j.jtemb.2021.126779_bib1785","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.10458","article-title":"The story of penicillamine: a difficult birth","volume":"18","author":"Walshe","year":"2003","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib1790","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/jat.2550120108","article-title":"Oral administration of d\u2010penicillamine causes neonatal mortality without morphological defects in cd\u20101 mice","volume":"12","author":"Rousseaux","year":"1992","journal-title":"J. Appl. Toxicol."},{"issue":"6","key":"10.1016\/j.jtemb.2021.126779_bib1795","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11938-005-0033-9","article-title":"Hepatic Wilson\u2019s disease: initial treatment and long-term management","volume":"8","author":"Walshe","year":"2005","journal-title":"Curr. Treat. Options Gastroenterol."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib1800","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0362-5478(76)90011-5","article-title":"Pharmacology and therapeutic applications of agents used in heavy metal poisoning","volume":"1","author":"Catsch","year":"1976","journal-title":"Pharmacol. Ther. Ser.A"},{"issue":"5","key":"10.1016\/j.jtemb.2021.126779_bib1805","article-title":"Why the NIH Trial to Assess Chelation Therapy (TACT) should be abandoned","volume":"10","author":"Atwood","year":"2008","journal-title":"Med. Gen. Med. Medscape General Med."},{"key":"10.1016\/j.jtemb.2021.126779_bib1810","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/8274504","article-title":"Rationale for the successful management of EDTA chelation therapy in human burden by toxic metals","volume":"2016","author":"Ferrero","year":"2016","journal-title":"Biomed Res. Int."},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib1815","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.gene.2013.02.049","article-title":"Deferiprone and idebenone rescue frataxin depletion phenotypes in a Drosophila model of Friedreich\u2019s ataxia","volume":"521","author":"Soriano","year":"2013","journal-title":"Gene"},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib1820","doi-asserted-by":"crossref","DOI":"10.15406\/japlr.2018.07.00230","article-title":"Pathophysiology and management of alzheimer\u2019s disease: an overview","volume":"7","author":"Kumar Thakur","year":"2018","journal-title":"J. Anal. Pharm. Res."},{"key":"10.1016\/j.jtemb.2021.126779_bib1825","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ccr.2018.03.010","article-title":"Metal-involved theranostics: An emerging strategy for fighting Alzheimer\u2019s disease","volume":"362","author":"Wang","year":"2018","journal-title":"Coord. Chem. Rev."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib1830","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40591-015-0039-1","article-title":"Polymeric nanocarriers for the treatment of systemic iron overload","volume":"3","author":"Hamilton","year":"2015","journal-title":"Mol. Cell. Ther."},{"issue":"6","key":"10.1016\/j.jtemb.2021.126779_bib1835","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/ijc.1537","article-title":"The copper-chelating agent, trientine, suppresses tumor development and angiogenesis in the murine hepatocellular carcinoma cells","volume":"94","author":"Yoshii","year":"2001","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.jtemb.2021.126779_bib1840","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2174\/1568026615666141209144506","article-title":"Antioxidant capacities of Flavones and benefits in oxidative-stress related diseases","volume":"15","author":"Catarino","year":"2015","journal-title":"Curr. Top. Med. Chem."},{"issue":"1","key":"10.1016\/j.jtemb.2021.126779_bib1845","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1467-4866-12-2","article-title":"Isolation and purification of Cu-free methanobactin from Methylosinus trichosporiumOB3b","volume":"12","author":"Pesch","year":"2011","journal-title":"Geochem. Trans."}],"container-title":["Journal of Trace Elements in Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0946672X21000699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0946672X21000699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T19:15:52Z","timestamp":1760555752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0946672X21000699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":369,"alternative-id":["S0946672X21000699"],"URL":"https:\/\/doi.org\/10.1016\/j.jtemb.2021.126779","relation":{},"ISSN":["0946-672X"],"issn-type":[{"value":"0946-672X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer\u2019s disease: Limitations, and current and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Journal of Trace Elements in Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtemb.2021.126779","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"126779"}}